Prescriber.io

Compare · Lexicomp

Lexicomp alternative that turns drug data into one decision-support card

Clinicians comparing Lexicomp alternatives tend to value its detailed drug monographs and dosing data but want a faster path from that detail to a decision. Lexicomp is a trusted, comprehensive drug-information resource that many pharmacists and prescribers rely on for granular monograph and dosing content, which is genuinely valuable when you need depth. The gap teams describe is that pulling the interaction, contraindication and dosing pieces together for a specific scenario can mean working across several monographs.

Prescriber.io focuses that detail into one actionable card. You enter the drug or scenario once and it checks for interactions, flags contraindications, surfaces renal and hepatic dose adjustments, and suggests guideline-based alternatives, with cited sources for each. It is decision-support, not autonomous prescribing: every flag is a prompt for you to review, verify against official sources, and sign off on.

The Monograph Desk

Press Run check to see the interaction, contraindication, and dosing decision-support card for this scenario.

Not in this sample

This on-page demo only ships with five illustrative scenarios and never invents clinical output, so it will not fake a card for this pair.

The full Prescriber.io desk checks any regimen against interactions, contraindications, and renal or hepatic dosing, with cited sources for you to verify.

Illustrative sample · decision-support only · verify against official sources

Interaction

Contraindication / allergy check

Dosing guidance (renal / hepatic)

Guideline-based alternatives

Sources

Illustrative sample · not real clinical advice · you verify and decide

Checked in · you review & sign

Decision support for licensed clinicians. Prescriber.io does not diagnose or prescribe and is not a substitute for professional clinical judgment.

See the comparison

Check · flag · suggest · you review and sign off

The short answer

Prescriber.io vs Lexicomp, in brief

Lexicomp is now sold by Wolters Kluwer as UpToDate Lexidrug, so a search for a Lexicomp alternative in 2026 usually means an alternative to Lexidrug. It remains a deep drug-information database, strongest for pharmacists and hospital teams who need monograph-level depth. There is no free tier: Apple's US App Store lists the personal subscription at $29.99 a month, and institutional pricing is negotiated per organization rather than published. Prescriber.io is a lighter, different thing: one point-of-care card that checks interactions, flags contraindications, surfaces renal and hepatic dose adjustments and suggests guideline-based alternatives for the prescription in front of you, with sources cited on each flag.

Last updated July 2026

Lexicomp is a detailed drug-information resource; Prescriber.io focuses interactions, contraindications, dose adjustment and guideline alternatives into one integrated point-of-care card with cited sources.

Side by side

Prescriber.io vs Lexicomp, honestly

A fair look at what each does well. Both are capable tools. Here is where they differ.

What matters Prescriber.io Lexicomp
Source of drug detail Pulls the relevant checks into one card per scenario Comprehensive monographs you read for depth
Drug interaction checking Flags interactions for the entered scenario in the card Detailed interaction data, often viewed per drug
Contraindication and allergy flags Surfaces contraindications and allergy blockers in the same card Documented within each monograph
Renal and hepatic dose adjustment Surfaces renal and hepatic dosing guidance alongside the checks Granular dosing data across monographs
Guideline-based alternatives Suggests alternatives with a one-line rationale to consider Reference-focused rather than suggested swaps
Best suited for Clinicians wanting one fast, citable check at the point of care Clinicians and pharmacists needing deep monograph detail

Comparison reflects general, publicly understood positioning. Capabilities change, so check each product for the latest.

Why clinicians pick Prescriber.io

One integrated check at the point of care

Detail, focused into a decision

Lexicomp is excellent when you need monograph depth. Prescriber.io focuses the parts that matter for a specific prescription, the interaction, contraindication and dosing checks, into one card so the detail becomes a fast, citable decision-support step.

One scenario, the checks together

Instead of working across several monographs for one decision, you enter the scenario once and the interaction, contraindication, dose-adjustment and alternatives checks arrive in one card, with sources you can confirm.

Decision-support, you always decide

Every flag and alternative is a prompt, not a directive. The licensed clinician reviews each one, verifies against official sources, and signs off. Prescriber.io supports your judgment and is not a substitute for it.

Good questions

Lexicomp vs Prescriber.io, answered

If you want the prescribing checks focused into one fast card rather than read across several monographs, yes. Lexicomp offers deep detail; Prescriber.io surfaces interactions, contraindications and dosing in one cited card. It is decision-support, and you verify against official sources and sign off.
It focuses on surfacing the interaction, contraindication and dosing checks you need to act on, with cited sources, rather than full monograph depth. It is decision-support only and is not a substitute for professional clinical judgment. Always verify against official sources.
Yes. Wolters Kluwer rebranded Lexicomp as UpToDate Lexidrug, and the vendor store and university library guides now list it as UpToDate Lexidrug (formerly Lexicomp). The mobile app still sells its subscription packages under the older Lexicomp names, which is why both appear on the same screen and why searching either name returns material about the other.
Apple's US App Store lists the personal UpToDate Lexidrug subscription at $29.99 per month after a trial, roughly $360 across a year. There is no free tier. Institutional pricing is never published and is negotiated per organization on user count, content sets and bundling, so treat any specific figure on a software directory site as guesswork.
Usually one of three reasons: the cost once an institutional license ends, the time it takes to assemble one decision from several monographs, or a move to a smaller practice that cannot justify an enterprise drug-information contract. Depth is rarely the complaint. Speed from detail to decision usually is.

See how Prescriber.io checks alongside your prescribing

One card that checks for drug interactions, flags contraindications, surfaces renal and hepatic dosing, and suggests guideline-based alternatives. You review, verify against official sources, and sign off.

See pricing

Decision-support for licensed clinicians. Prescriber.io does not diagnose or prescribe autonomously and is not a substitute for professional clinical judgment. Always verify against official sources.